AIG vs DMAC · P/E 21, rev $7.18B vs $157.4M cap
American International Group Inc (AIG) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
American International Group Inc (AIG) is a insurance - diversified company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported AIG revenue for 2024-12-31 was $7.18B. Net income was $901.0M. Revenue was up 6.3% from 2024-09-30 to 2024-12-31. AIG currently screens at market cap $48.97B and trailing P/E 20.6.
DMAC does not have a complete income-statement cache yet.
AIG currently screens at market cap $48.97B and trailing P/E 20.6. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the AIG and DMAC stock pages for the full models.
Not investment advice.